Abstract:Recent studies have defined a crucial role for the B cell-activating factor belonging to TNF family (BAFF) in promoting germinal center (GC) responses in mouse model. BAFF-deficient (BAFF-/-) mouse was defective in primary B cell survival and development, including a loss of transitional type 2, follicular, and marginal zone B cells. This fact prompted us to investigate the influence of BAFF on follicular helper T (Tfh) cells, another important subset that helps antibody production in GC. In vivo, various strains of mice were immunized with keyhole limpet hemocyanin (KLH) emulsified in CFA. We first observed that BAFF deficiency impairs GC B cell responses to T cell dependent antigens. We also found that BAFF-/- mice, but not APRIL-/- mice, have a defect on the generation of Tfh cells and antibody production. Similar to BAFF-/- mice, BR3-/- mice also showed almost none of Tfh cells in draining lymph node. While BCMA-/- or TACI-/- mice appeared to be normal or even higher percentage of Tfh cells in spleen and lymph node after antigen stimulation. Thus, BAFF might upregulate the Tfh cells via BR3, rather than BCMA or TACI, all of which are BAFF receptors. To rule out the influence of impaired B cell by BAFF, Bcl2 Tg and BAFF-/-Bcl2 Tg mice were employed for keeping survival B cells in BAFF deficient background. To the end, we found that lack of BAFF still caused impaired Tfh cell and antibody production. With a co-transfer experiment, we further comfirmed that BAFF is required for the differentiation of Tfh cells and production of GC B cells. In vitro, we demonstrated that BAFF increases IL-21 mRNA expression in CD4+ T cells, and IL-6 mRNA expression in B cells and dendritic cells. In summary, these findings provide evidence that BAFF promotes Tfh development, germinal center generation and pathogenesis of autoimmune diseases.

Protective effects of p-nitrophenylalanine-containing BAFF vaccine on lupus nephritis model mice

BAFF Promotes FLS Activation Through BAFFR-Mediated Non-canonical NF-κB Pathway and the Effects of CP-25.

Effects of human soluble BAFF synthesized in Escherichia coli on CD4 + and CD8+ T lymphocytes as well as NK cells in mice

A Novel BAFF Antagonist, BAFF-Trap, Effectively Alleviates the Disease Progression of Systemic Lupus Erythematosus in MRL/lpr Mice

Humanized BAFF Transgenic Mice Develop Autoimmune Manifestations

A Novel Human Anti-Baff Neutralizing Monoclonal Antibody Derived from in Vitro Immunization.

Therapeutic Effects of PADRE-BAFF Autovaccine on Rat Adjuvant Arthritis

Effect of BAFF blockade on the B cell receptor repertoire and transcriptome in a mouse model of systemic lupus erythematosus

Preparation and bioactivity characterization of recombinant human soluble mutant BAFF

Blockade of B-cell-activating Factor Suppresses Lupus-Like Syndrome in Autoimmune BXSB Mice

Expressions of BAFF/BAFF Receptors and Their Correlation with Disease Activity in Chinese SLE Patients

BAFF-targeting Therapy, a Promising Strategy for Treating Autoimmune Diseases

[Advances of using antibody against B cell activating factor for treatment of autoimmune diseases].

The Unknown Aspect of BAFF: Inducing IL-35 Production by a CD5+CD1dhiFcγRIIbhi Regulatory B-Cell Subset in Lupus.

Molecular Structure, Expression, and Bioactivity of B-cell-activating Factor of the TNF Family (BAFF) and Its Receptor BAFF-R in Cats (felis Catus).

BAFF Binding to T Cell-Expressed BAFF-R Promotes Follicular Helper T Cell Proliferation and GC B Cell Responses

Therapeutic Effects of a Novel BAFF Blocker on Arthritis

Preliminary clinical measurement of the expression of B-cell activating factor in Chinese systemic lupus erythematosus patients.

A Benzenediamine Derivate FC-99 Attenuates Lupus Nephritis in MRL/lpr Mice Via Inhibiting Myeloid Dendritic Cell-Secreted BAFF

EFFECTS OF SPLENIC B LYMPHOCYTE PROLIFERATION AND RESPONSE AND INTRACELLULAR Ca2+ OF Hsbaff IN MICE

Expression,purification and bioactivity identification of recombinant human BAFF fusion protein